Laser Focus World is an industry bedrock—first published in 1965 and still going strong. We publish original articles about cutting-edge advances in lasers, optics, photonics, sensors, and quantum technologies, as well as test and measurement, and the shift currently underway to usher in the photonic integrated circuits, optical interconnects, and copackaged electronics and photonics to deliver the speed and efficiency essential for data centers of the future.

Our 80,000 qualified print subscribers—and 130,000 12-month engaged online audience—trust us to dive in and provide original journalism you won’t find elsewhere covering key emerging areas such as laser-driven inertial confinement fusion, lasers in space, integrated photonics, chipscale lasers, LiDAR, metasurfaces, high-energy laser weaponry, photonic crystals, and quantum computing/sensors/communications. We cover the innovations driving these markets.

Laser Focus World is part of Endeavor Business Media, a division of EndeavorB2B.

Laser Focus World Membership

Never miss any articles, videos, podcasts, or webinars by signing up for membership access to Laser Focus World online. You can manage your preferences all in one place—and provide our editorial team with your valued feedback.

Magazine Subscription

Can you subscribe to receive our print issue for free? Yes, you sure can!

Newsletter Subscription

Laser Focus World newsletter subscription is free to qualified professionals:

The Daily Beam

Showcases the newest content from Laser Focus World, including photonics- and optics-based applications, components, research, and trends. (Daily)

Product Watch

The latest in products within the photonics industry. (9x per year)

Bio & Life Sciences Product Watch

The latest in products within the biophotonics industry. (4x per year)

Laser Processing Product Watch

The latest in products within the laser processing industry. (3x per year)

Get Published!

If you’d like to write an article for us, reach out with a short pitch to Sally Cole Johnson: [email protected]. We love to hear from you.

Photonics Hot List

Laser Focus World produces a video newscast that gives a peek into what’s happening in the world of photonics.

Following the Photons: A Photonics Podcast

Following the Photons: A Photonics Podcast dives deep into the fascinating world of photonics. Our weekly episodes feature interviews and discussions with industry and research experts, providing valuable perspectives on the issues, technologies, and trends shaping the photonics community.

Editorial Advisory Board

  • Professor Andrea M. Armani, University of Southern California
  • Ruti Ben-Shlomi, Ph.D., LightSolver
  • James Butler, Ph.D., Hamamatsu
  • Natalie Fardian-Melamed, Ph.D., Columbia University
  • Justin Sigley, Ph.D., AmeriCOM
  • Professor Birgit Stiller, Max Planck Institute for the Science of Light, and Leibniz University of Hannover
  • Professor Stephen Sweeney, University of Glasgow
  • Mohan Wang, Ph.D., University of Oxford
  • Professor Xuchen Wang, Harbin Engineering University
  • Professor Stefan Witte, Delft University of Technology

Optime Care Terminates Distributor Agreement for Korlym® (mifepristone)

ST. LOUIS, Oct. 09, 2025 (GLOBE NEWSWIRE) -- Following 10+ years of service to Cushing's syndrome patients, Optime Care, a national specialty pharmacy, distribution and patient management organization maximizing therapeutic opportunities for the treatment of orphan and rare disorders, today announces termination of its agreement as the distributor for Korlym® (mifepristone).

Reinforcing its commitment to patient-centric care and drawing upon specialized experience and expertise to optimize each individual patient treatment journey, adherence to therapy and clinical outcomes, Optime Care prides itself on timely access and affordability of life-changing therapies.

Donovan Quill, founder, Optime Care, says, “We are proud of our team’s support and dedication to Korlym® patients. We have been their exclusive distributor for over 10 years and it saddens me that we will no longer be servicing these patients that we have grown to know and care for over the past decade. Our exclusive distribution model remains an important strategic tool for rare and orphan drug manufacturers who prioritize patient-first care while expanding market share. We terminated this agreement for Korlym based upon the decision by the drug manufacturer to end its exclusive arrangement with us, representing a material change that is not aligned with our model for treating special patients. As a respected partner to industry stakeholders, Optime Care provides the efficiency and scalability needed to build momentum and navigate ongoing challenges.”

Emphasizing the value of its patient-centric care model, Bill Oldham, chairman, continues, “We believe strongly in our approach which is designed to support the needs of patients with rare and ultra-rare conditions. We understand there are other models, but our priority is to support product distribution implementation strategies that reflect our values, our ethics and a focus on the patient, allowing our professional teams to do their best work for the patients we serve.”

Looking ahead, Optime Care will move forward with a continued vision for growth and further expansion of our business pipeline, innovation, service excellence and most importantly, a dedication to patients across the specialty pharmacy and rare disease landscape.

About Optime Care
Optime Care, Inc. is a nationally recognized specialty pharmacy, distribution and patient management organization offering a suite of comprehensive services tailored to maximize therapeutic opportunities for the treatment of orphan and rare disorders. The executive team has partnered in the launch and management of over 40 orphan products and programs while consistently implementing the best brand services for the community. Optime Care has dual-accreditation from the Utilization Review Accreditation Commission (URAC) for compliance with specialty pharmacy and the Accreditation Commission for Health Care (ACHC) for specialty pharmacy services that demonstrate a commitment to providing quality care and services to consumers.

Media:
Esther Jin
CPR Communications
ejin@cpronline.com
201.645.4896 x 10

This press release was published by a CLEAR® Verified individual.


Primary Logo

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.